Vericel Corp. (VCEL)
38.33
+0.46
(+1.21%)
USD |
NASDAQ |
Sep 11, 16:00
38.33
0.00 (0.00%)
After-Hours: 16:21
Vericel Gross Profit (TTM) : 228.38M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 228.38M |
| March 31, 2026 | 218.59M |
| December 31, 2025 | 205.60M |
| September 30, 2025 | 190.97M |
| June 30, 2025 | 183.04M |
| March 31, 2025 | 173.03M |
| December 31, 2024 | 172.11M |
| September 30, 2024 | 162.12M |
| June 30, 2024 | 151.07M |
| March 31, 2024 | 144.41M |
| December 31, 2023 | 135.58M |
| September 30, 2023 | 125.32M |
| June 30, 2023 | 119.94M |
| March 31, 2023 | 112.86M |
| December 31, 2022 | 109.79M |
| September 30, 2022 | 105.57M |
| June 30, 2022 | 102.44M |
| March 31, 2022 | 106.49M |
| December 31, 2021 | 106.02M |
| September 30, 2021 | 105.64M |
| June 30, 2021 | 106.01M |
| March 31, 2021 | 90.46M |
| December 31, 2020 | 84.23M |
| September 30, 2020 | 79.39M |
| June 30, 2020 | 78.09M |
| Date | Value |
|---|---|
| March 31, 2020 | 83.86M |
| December 31, 2019 | 80.28M |
| September 30, 2019 | 74.18M |
| June 30, 2019 | 67.35M |
| March 31, 2019 | 61.51M |
| December 31, 2018 | 58.70M |
| September 30, 2018 | 50.95M |
| June 30, 2018 | 43.68M |
| March 31, 2018 | 41.68M |
| December 31, 2017 | 33.57M |
| September 30, 2017 | 27.54M |
| June 30, 2017 | 24.54M |
| March 31, 2017 | 20.78M |
| December 31, 2016 | 26.08M |
| September 30, 2016 | 25.34M |
| June 30, 2016 | 25.80M |
| March 31, 2016 | 26.96M |
| December 31, 2015 | 24.70M |
| September 30, 2015 | 24.46M |
| June 30, 2015 | 24.15M |
| March 31, 2015 | 19.28M |
| December 31, 2014 | 13.91M |
| September 30, 2014 | 5.857M |
| June 30, 2014 | 1.519M |
| March 31, 2014 | -0.398M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| AbbVie, Inc. | 45.98B |
| ADMA Biologics, Inc. | 331.27M |
| Kyntra Bio, Inc. | 0.076M |
| Conexeu Sciences, Inc. | -0.0148M |
| ACADIA Pharmaceuticals, Inc. | 1.038B |